References
1. Commonwealth Department of Health and Aged Care. General practice in Australia: 2000. Canberra: Commonwealth Department of Health and Aged Care, 2000, p. 311-44.
2. UK National Health Services, UK National Screening Committee, 2004. Available at www.nsc.nhs.uk/index.htm.
3. Wilson J, Jungner Y. Principles and practices of screening for disease. Geneva: World Health Organization, 1968.
4. World Health Organization. Screening for various cancers. 2005. Available at www.who.int/cancer/detection/variouscancer/en/.
5. National Standing Committee – Quality Care. Smoking, Nutrition, Alcohol and Physical activity (SNAP): A population health guide to behavioural risk factors in general practice. Harris PM, editor. Melbourne: The RACGP, 2004.
6. Aldrich R, et al. Using socioeconomic evidence in clinical practice guidelines. BMJ 2003;327:1283–5.
7. Bouleware LE, et al. Systematic review: The value of the periodic health evaluation. Ann Intern Med 2007;146:289–300.
8. Whitehead M. The concepts and principles of equity and health. Copenhagen: World Health Organization, Regional Office for Europe, 1990.
9. Mathers C, Vos T, Stevenson C. The burden of disease and injury in Australia. Canberra: Australian Institute of Health and Welfare, 1999.
10. Wilson AJ, Oldenburg BF, Lopez AD. Targeted approaches for reducing inequities in chronic disease. Med J Australia 2003;179:231–2.
11. Rychetnik L, et al. Criteria for evaluating evidence on public health interventions. J Epidemiol Commun Health 2002;56:119–27.
12. Glover J, Hetzel D, Tennant S. The socioeconomic gradient and chronic illness and associated risk factors in Australia. Aust New Zealand Health Policy 2004;1:8.
13. Wiggers JH, Sanson-Fisher RW. Practitioner provision of preventive care in general practice consultations: association with patient education and occupational status. Soc Sci Med 1997;44:137–46.
14. Harris M, Furler J. How can primary care increase equity in health? New South Wales Public Health Bulletin 2002;13:35–8.
15. Victorian Foundation for Survivors of Torture and Western Melbourne Division of General Practice. Caring for refugee patients in general practice: A desk-top guide. Melbourne: Victorian Foundation for Survivors of Torture Inc, 2000.
16. NSW Refugee Health Service. Managing survivors of torture and refugee trauma: Guidelines for general practitioners. Sydney: NSW Refugee Health Service, 2000.
17. Stanton J, Kaplan I, Webster K. Role of Australian doctors in refugee health care. Current Therapeutics 1999;40:24–8.
18. Australian Institute of Health and Welfare. Health in rural and remote Australia. AIHW Cat. No. PHE 6. Canberra: AIHW, 1998.
19. Britt H, Miller G, Valenti L. ‘It’s different in the bush’. A comparison of general practice activity in metropolitan and rural areas of Australia 1998–2000. AIHW Cat. No. GEP 6. Australian Institute of Health and Welfare. (General Practice Series No. 6). Canberra: AIHW, 2001.
20. Turrell G, et al. Utilisation of general practitioner services by socio-economic disadvantage and geographic remoteness. Aust N Z J Public Health 2004;28:152–8.
21. Hall RH. Promoting men’s health. Aust Fam Physician 2003;32:401–7.
22. Dolan M, et al. A meta-analysis of trials evaluating patient education and counselling for three groups of preventive health behaviours. Oxford: Cochrane Review, 1997.
23. Wallace LS, et al. Screening items to identify patients with limited health literacy skills. J Gen Med 2006;21:874–7.
24. Trachtenberg F, Dugan E, Hall M. How patients’ trust relates to their involvement in medical care. J Fam Pract 2005;54:344–52.
25. Ellis S, et al. Diabetes patient education: a meta-analysis and meta-regression. Pat Educ Couns 2004;52:97–105.
26. Lewin S, et al. Interventions for providers to promote a patient-centred approach in clinical consultations. Cochrane Database Syst Rev 2002;4(CD003267).
27. Mead N, Bower P. Patient-centred consultations and outcomes in primary care. Patient Educ Counsel 2002;48:51–61.
28. Rao J, Weinberger M, Kroenke K. Visit-specific expectations and patient-centred outcomes: literature review. Arch Fam Med 2000;9:1148–55.
29. Littell J, Girvin H. Stages of change: a critique. Behav Modif 2002;26:223–73.
30. Schauffler H, Rodriguez T, Milstein A. Health education and patient satisfaction. J Fam Pract 1996;42:62–8.
31. Ley P. Patients’ understanding and recall in clinical communication failure. In: Doctor Patient Communication. Pendleton D, Hasler J, editors. London: Academic Press, 1983.
32. Steptoe A, et al. The impact of behavioral counseling on stage of change in fat intake, physical activity, and cigarette smoking in adults at increased risk of coronary heart disease. Am J Public Health 2001;91:265–9.
33. Branch L, Rabiner D. Rediscovering the patient’s role in receiving health promotion services. Med Care 2000;38:70–7.
34. O’Connor A, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2003;2:(CD001431).
35. Warsi A, et al. Self-management education programs in chronic disease: a systematic review and methodologic critique of the literature. Arch Intern Med 2004;164:1641–9.
36. Ofman J, et al. Does disease management improve clinical and economic outcomes in patients with chronic diseases? A systematic review. Am J Med 2004;117:182–92.
37. Joos S, et al. Effects of physician communication intervention on patient care outcomes. J Gen Intern Med 1996;11:147–55.
38. Hibbard J. Engaging health care consumers to improve quality of care. Med Care 2003;41(1 Suppl):I61–70.
39. Bodenheimer T, Wagner E, Grumbach K. Improving primary care for patients with chronic illness. JAMA 2002;288:1775–9.
40. Rosenstock I. The health belief model and preventative health behaviour. Health Education Monographs 1974;2:27–57.
41. Cassidy C. Using the transtheoretical model to facilitate behaviour change in patients with chronic illness. Journal of American Academic Nurse Practise 1999;11:281.
42. Access Seru, CHETRE, and Integration SERU. Action on health inequalities through general practice. A discussion paper. 1998.
43. Commonwealth Department of Health and Aged Care. General practice in Australia: 2000. Canberra: AIHW, 2000.
44. United States Preventive Services Task Force. Guide to clinical preventive services. 2nd edn. Baltimore: Williams and Wilkins, 1996.
45. Johnson K, et al. Recommendations to improve preconception health and health care-United States. MMWR Recomm Rep 2006;55(RR–6):1–23.
46. Lumley J, et al. Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 2004;4.
47. National Health and Medical Research Council. Australian alcohol guidelines for low-risk drinking. Canberra: NHMRC, in press.
48. Lumley J, et al. Periconceptual supplementation with folate and/or multivitamins for preventing neural tube defects (Cochrane review). Oxford: The Cochrane Library, 2001.
49. National Health and Medical Research Council. Australian Immunisation Handbook. 9th edn. Canberra: NHMRC, 2008.
50. Australian Department of Health and Aged Care. Prescribing medicines in pregnancy. 4th edn. Therapeutic Goods Administration, 1999.
51. Korenbrot CC, et al. Preconception care: a systematic review. Matern Child Health J 2002;6:75–88.
52. Gjerdingen DK, Fontaine P. Preconception health care: A critical task for family physicians. J Am Board Fam Pract 1991;4:237–50.
53. de Jong-Potjer LC, et al. GP-initiated preconception counselling in a randomised controlled trial does not induce anxiety. BMC Fam Pract 2006;7:66.
54. US Preventive Services Task Force. Guide to clinical preventive services. 2nd edn. Washington, DC: Office of Disease Prevention and Health Promotion, 2004.
55. Wilson RD, et al. Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can 2007;29:1003–26.
56. National Collaborating Centre for Women’s and Children’s Health. Diabetes in pregnancy: Management of diabetes and its complications from preconception to the postnatal period. NICE, 2008.
57. Zwar N, et al. Smoking cessation guidelines for Australian general practice. Canberra: Commonwealth Department of Health and Ageing, 2004.
58. Conde-Agudelo A, Rosas-Bermúdez A, Kafury-Goeta AC. Birth spacing and risk of adverse perinatal outcomes: A meta-analysis. JAMA 2006;295:1809–23.
59. Watson LF, Brown SJ, and Davey MA. Use of periconceptional folic acid supplements in Victoria and New South Wales, Australia. Aust N Z J Public Health 2006;30:42–9.
60. Lees C, Smythe R. Antenatal screening for cystic fibrosis (Protocol for a Cochrane Review). In: The Cochrane Library. Oxford: Update Software, 2000.
61. Merelle M, et al. Newborn screening for cystic fibrosis (Cochrane Review). In: The Cochrane Library. Oxford: Update Software, 2001;3.
62. Genetics Education in Medicine Consortium. Genetics in family medicine: The Australian Handbook for General Practitioners, 2008. Available at www.gpgenetics.edu.au.
63. Facher J, Robin N. Genetic counselling in primary care. What questions are patients likely to ask, and how should they be answered. Postgrad Med 2000;107:59–66.
64. Dick P. Periodic health examination, 1996 update. 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination. CMAJ 1996;154:465–79.
65. Emery J, et al. Genetics and preventive health care. Aust Fam Physician 2007;36:808–11.
66. Powell LW, et al. Screening for hemochromatosis in asymptomatic subjects with or without a family history. Arch Intern Med 2006;166:294–303.
67. Whitlock EP, et al. Screening for Hemochromatosis: Recommendations from the U.S. Preventive Services Task Force. Ann Intern Med 2006;145:209–23.
68. Modell M, et al. A multidisciplinary approach for improving services in primary care: a randomised controlled trial of screening for haemoglobin disorders. BMJ 1998;317:788–91.
69. Cao A, Galanello R, Beta-Thalassemia. In: GeneTests Reviews. Seattle: University of Washington, 2003.
70. Jean Hailes Foundation. Menopause - premature (early menopause), 2003. Available at www.betterhealth.vic.gov.au/bhcv2/bhcarticles.nsf/pages/Menopause_premature_early_ menopause?OpenDocument.
71. Cohen J, Lennox N. Fragile X syndrome. In: Management guidelines: People with developmental and intellectual disabilities. Lennox N, editor. Therapeutic Guidelines Ltd, 1999.
72. Laml T, et al. Genetic disorders in premature ovarian failure. Hum Reprod Update 2002;8:483–91.
73. Jacquemont S, et al. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA 2004;291:460–69.
74. National Health and Medical Research Council. Current best advice about familial aspects of breast cancer: a guide for general practitioners. Woolloomooloo: National Breast Cancer Centre, 1999.
75. Barratt A, et al. Model of outcomes of screening mammography: information to support informed choices. BMJ 2005;330:936.
76. Meijers-Heijboer H, et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2001;345:159–64.
77. Lostumbo L, et al. Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev 2004;4:CD002748.
78. Rebbeck T, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 2004;22:1055–62.
79. Khoury-Collado F, Bombard A. Hereditary breast and ovarian cancer: what the primary care physician should know. Obstet Gynecol Surv 2004;59:537–42.
80. Pierce L. Radiotherapy for breast cancer in BRCA1/BRCA2 carriers: clinical issues and management dilemmas. Semin Radiat Oncol 2002;12:352–61.
81. Abdullah AS, et al. Smoking cessation intervention in parents of young children: a randomised controlled trial. Addiction 2005;100:1731–40.
82. National Health and Medical Research Council. Child health screening and surveillance: a critical review of the evidence. Canberra: NHMRC, 2002.
83. Fry T. If it’s worth doing, let’s do it. Arch Dis Child 2008;93:267–8.
84. Vimpani G, Patton G, Hayes A. The relevance of child and adolescent development for outcomes in education, health and life success, in children’s health and development: new research directions for Australia. Sanson A, editor. Melbourne: Australian Institute of Family Studies, 2002, p. 14–37.
85. National Public Health Partnership. Healthy children – strengthening promotion and prevention across Australia: Developing a National Public Health Action Plan for Children 2005–2008 – Consultation Paper. Melbourne: NPHP, 2004.
86. Canadian Task Force on Periodic Health Examination. The Canadian guide to clinical preventive health care. Ottawa: 2000.
87. Clemens R. Issues in newborn care. Primary Care Resp J 2000;27:251–69.
88. Hickey A, et al. Early discharge and risk for postnatal depression. MJA 1997;167:244–7.
89. Milgrom J, et al. Antenatal risk factors for postnatal depression: a large prospective study. J Affect Disord 2007;108:147–57.
90. Leigh B, Milgrom J. Risk factors for antenatal depression, postnatal depression and parenting stress. BMC Psychiatry 2008;8:24.
91. Sanders MR, et al. Every Family: A public health approach to promoting children’s wellbeing – final report. Brisbane: University of Queensland, 2007.
92. Clamp M, Kendrick D. A randomized controlled trial of general practitioner safety advice for families with children under 5 years. BMJ 1998;316:1576–9.
93. Kendrick D. Preventing injuries in children: cluster randomized controlled trial in primary care. BMJ 1999;318:980–3.
94. Robinson PD, et al. The re-emerging burden of rickets: a decade of experience from Sydney. Arch Dis in Child 2006;91:564–8.
95. Osteoporosis Australia. Risks and benefits of sun exposure position statement. Sydney: Osteoporosis Australia, 2005.
96. Barlow SE, the Expert Committee. Expert Committee recommendations regarding the prevention, assessment and treatment of child and adolescent overweight and obesity. Summary report. Pediatrics 2007;120:S164–S192.
97. National Health and Medical Research Council. Dietary guidelines for children and adolescents in Australia: a guide to healthy eating. Canberra: Commonwealth of Australia, 2003.
98. US Department of Health and Human Services. 2008 physical activity guidelines for Americans. Washington DC: US Department of Health and Human Services, 2008.
99. Li M, et al. Declining iodine content of milk and re-emergence of iodine deficiency in Australia. Med J Aust 2006;184:307.
100. National Health and Medical Research Council. Clinical practice guidelines for the management of overweight and obesity in children and adolescents. Canberra: Commonwealth of Australia, 2003.
101. Spurrier NJ, Magarey A, Wong C. Recognition and management of childhood overweight and obesity by clinicians. J Paediatr Child Health 2006;42:411–8.
102. DeMattia L, Denney SL. Childhood obesity prevention: successful community- based efforts. Ann Am Acad Pol Soc Sci 2008;615:83–99.
103. O’Connor J, et al. Evaluation of a community-based weight management program for overweight and obese adolescents: The Loozit study. J Nutr Diet 2008;65:121–7.
104. Fayter D, et al. Effectiveness and cost effectiveness of height screening programmes during the primary school years: a systematic review. Arch Dis Child 2008;93:278–84.
105. Grote FK, et al. Developing an evidence-based guideline for the referral of short stature. Arch Dis Child 2008;93:212–7.
106. Liaw T, Lawrence M, Rendell J. The effect of a computer-generated patient-held medical record summary and/or a written personal health record on patient’s attitudes, knowledge and behaviour concerning health promotion. Fam Pract 1996;13:289–93.
107. NSW Health. The NSW parent held record, ‘my first health record’, 2008. Available at www.health.nsw.gov.au/pubs/2007/child_health_record.html.
108. Booth M, et al. NSW Schools Physical Activity and Nutrition Survey (SPANS) 2004: full report. Sydney: NSW Health, 2006.
109. Canadian Paediatrics Society. A health professional’s guide to using growth charts. Paediatr Child Health 2004;9:174–6.
110. Gerner B, et al. Are general practitioners equipped to detect child overweight/obesity? Survey and audit. J Paediatr Child Health 2006;42:206.
111. Wake MA. Newborn hearing screening: decision time for Australia. Med J Aust 2002;177:172–3.
112. Sids and Kids. Safe sleeping, 2007. Available at www.sidsandkids.org/documents/SidsSafeSleeping14ppa_000.pdf.
113. O’Donnell M, Scott D, Stanley F. Child abuse and neglect – is it time for a public health approach? Aust N Z J Public Health 2008; in press.
114. Drotar D, Stancin T, Dworkin P. Pediatric developmental screening: understanding and selecting screening instruments, 2008. Available at www.commonwealthfund.org/publications/publications_show.htm?doc_id=614864&trackTitle=Pediatric%20Developmental%20Screening:%20Understanding%20and%20Selecting%20Screening%20Instruments&trackLable=email-friend_Publications.
115. University of Queensland. Positive parenting program, 2008. Available at www.pfsc.uq.edu.au/index.html.
116. Glew GM, et al. Bullying and school safety. J Pediatr 2008;152:123–8.
117. Rigby K. Consequences of bullying in schools. Can J Psychiatry 2003;48:583–90.
118. Kaltiala-Heino R, et al. Bullying at school – an indicator of adolescents at risk for mental disorders. J Adolesc 2000;23:661–74.
119. Morita Y, et al. Japan, in the nature of school bullying. A cross-national perspective. Smith PK, et al, editors. London: Routledge, 1999;309–23.
120. Hoghughi M. The importance of parenting in child health. Doctors as well as governments should do more to support parents. BMJ 1998;316:1545.
121. Adolescent Health Committee and Canadian Paediatric Society. Harm reduction: an approach to reducing risky health behaviours in adolescents. Paediatr Child Health 2008;13:53–6.
122. NSW Health. Transition care, 2007. Available at www.health.nsw.gov.au/gmct/transition.
123. Sawyer SM, Aroni RA. Self management in adolescents with chronic illness. What does it mean and how can it be achieved? Med J Aust 2005;183:405–9.
124. Honey A, et al. Transition of adolescents with chronic health conditions from paediatric to adult services: literature overview. ARACY Collaboration, 2008.
125. The Royal Australian College of General Practitioners. Children’s and young people’s health. In: The RACGP Curriculum for Australian general practice. Melbourne: The RACGP, 2007.
126. Dowell AC, et al. Prevention in practice: results of 2-year follow-up of routine health promotion interventions in general practice. Fam Pract 1996;13:357–62.
127. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ 1995;310:1099–104.
128. Engberg M, et al. General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5-year follow-up. J Fam Pract 2002;51:546–52.
129. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study. BMJ 1994;308:313–20.
130. Raftery JP, et al. Cost effectiveness of nurse led secondary prevention clinics for coronary heart disease in primary care: follow up of a randomised controlled trial. BMJ 2005;330:707.
131. Cassidy C. Using the transtheoretical model to facilitate behaviour change in patients with chronic illness. J Am Acad Nurse Pract 1999;11:281.
132. The Royal Australian College of General Practitioners. Putting prevention into practice: guidelines for the implementation of prevention in the general practice setting. 2nd edn. Melbourne: The RACGP, 2006.
133. Department of Health and Ageing. The carer experience: an essential guide for carers of people with dementia. Canberra: Commonwealth of Australia, 2002.
134. Argimon J, et al. Health-related quality of life in carers of patients with dementia. Fam Pract 2004;21:454–7.
135. Mafullul Y. Burden of informal carers of mentally infirm elderly in Lancashire. East Afr Med J 2002;79:291–8.
136. Smith L, et al. Impact and influence on caregiver outcomes at one year post-stroke. Cerebrovascular Disease 2004;18:145–53.
137. Hare P. Keeping carers healthy: the role of community nurses and colleagues. Br J Community Nurs 2004;9:155–9.
138. Bruce D, et al. Communication problems between dementia carers and general practitioners: effect on access to community support services. Med J Aust 2002;177:186–8.
139. Australian Bureau of Statistics. Disability ageing and carers: summary of findings in Australia, 1999. Available at www.abs.gov.au/Websitedbs/c311215.nsf/0/29AC3ED8564FE715CA256943002C4E3C?Open.
140. Droes R, et al. Effect of meeting centres support program on feelings of competence of family carers and delay of institutionalization of people with dementia. Ageing and Mental Health 2004;8:2001–11.
141. Marriott A, et al. Effectiveness of cognitive-behavioural family intervention in reducing the burden of care in carers of patients with Alzheimer’s disease. British Journal of Psychiatry 2000;176:557–62.
142. National Falls Prevention for Older People Initiative. An analysis of research on preventing falls and falls injury in older people: Community, residential care and hospital settings. Canberra: Australian Government Department of Health and Ageing, 2004.
143. Nelson ME, et al. Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 2007;39:1435–45.
144. Coleman AL, et al. Higher risk of multiple falls among elderly women who lose visual acuity. Ophthalmology 2004;111:857–62.
145. Hodge W, et al. The consequences of waiting for cataract surgery: a systematic review. Can Med Assoc J 2007;176:1285–90.
146. Taylor H, Keeffe J. Updates in medicine: ophthalmology. Med J Aust 2002;176:29.
147. Gillespie L, et al. Interventions for preventing falls in elderly people. The Cochrane Database of Syst Rev 2003;4.
148. Chang JT, et al. Interventions for the prevention of falls in older adults: systematic review and metaanalysis of randomised clinical trials. BMJ 2004;328:680.
149. Bischoff-Ferrari HA, et al. Effect of vitamin D on falls: a meta-analysis. JAMA 2004;291:1999–2006.
150. Scott V, et al. Multifactorial and functional mobility assessment tools for fall risk among older adults in community, home-support, long-term and acute care settings. Age Ageing 2007;36:130–9.
151. Weiner D, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004;15:1307–15.
152. American Geriatric Society, British Geriatrics Society, AAoOS Guideline for the prevention of falls in older persons. J Am Geriatr Soc 2001;49:664–72.
153. Podsiadlo D, Richardson S. The timed ‘up & go’: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991;39:142–8.
154. National Institute for Clinical Excellence. Clinical practice guideline for the assessment and prevention of falls in older people. London: NICE, 2004.
155. Zijlstra GA, et al. Interventions to reduce fear of falling in community-living older people: a systematic review. J Am Geriatr Soc 2007;55:603–15.
156. Wyman JF, et al. Effectiveness of education and individualized counselling in reducing environmental hazards in the homes of community-dwelling older women. J Am Geriatr Soc 2007;55:1548–56.
157. Smeeth L, Iliffe S. Community screening for visual impairment in the elderly. Cochrane Database Syst Rev 2006;3:CD001054.
158. Austroads. Assessing fitness to drive, commercial and private vehicle drivers: medical standards for licensing and clinical management guidelines, 2003. Available at www.austroads.com.au/aftd/index.html.
159. Australian Institute of Health and Welfare. Australia’s health 2006. Canberra: AIHW, 2006.
160. Canadian Task Force on the Periodic Health Examination. Periodic health examination, 1995 update: 3. screening for visual problems among elderly patients. Can Med Assoc J 1995;152:1211–22.
161. Patterson C. Screening for visual impairment in the elderly, in Canadian task force on the periodic health examination. Canadian Guide to Clinical Preventive Health Care. Ottawa: Health Canada 1994;932–42.
162. Patterson C. Prevention of hearing impairment and disability in the elderly, in Canadian task Force on the periodic health examination. Canadian Guide to Clinical Preventive Health Care. Ottawa: Health Canada 1994;954–63.
163. The Royal Australian College of General Practitioners, NSW Health. Care of patients with dementia in general practice: guidelines. Sydney: NSW Department of Health, 2003.
164. Boustani M, et al. Screening for dementia in primary care: a summary of the evidence for the U.S. preventive services task force. Ann Intern Med 2003;138:927–37.
165. National Collaborating Centre for Mental Health. Dementia: A NICE-SCIE guideline on supporting people with dementia and their carers in health and social care. London: NICE, 2007.
166. Kirby M, et al. The clock drawing test in primary care: sensitivity in dementia detection and specificity against normal and depressed elderly. Int J Geriatr Psychiatry 2001;16:935–40.
167. Brodaty H, et al. The GPCOG: a new screening test for dementia designed for general practice. J Am Geriatr Soc 2002;50:530–4.
168. DeLepeleire J, et al. A combination of tests for the diagnosis of dementia had significant diagnostic value. J Clin Epidemiol 2005;58:217–25.
169. Storey J, et al. The Rowland Universal Dementia Assessment Scale (RUDAS): a multicultural cognitive assessment scale. Int Psychogeriatr 2004;16:13–31.
170. Legislative Council of Western Australia. Report of the select committee on immunisation and vaccination rates in children. Perth: 1999.
171. Australian Bureau of Statistics. 1989/90 national health survey. Canberra: Australian Government Publishing Service, 1996.
172. Bell J, et al. The epidemiology of incomplete childhood immunisation: an analysis of reported immunisation status in western Sydney. J Paediatr Child Health 1993;28:451–4.
173. Herceg A, et al. A population based survey of immunisation coverage in two year old children. Aust J Public Health 1995;19:465–70.
174. Jones K, et al. Immunisation status of casualty attenders: risk factors for non-compliance and attitudes to ‘on the spot’ immunisation. J Paediatr Child Health 1992;28:451–4.
175. Australian Bureau of Statistics. Children’s immunisation Australia april 1995. Canberra: Australian Government Publishing Service, 1996.
176. Skinner J, March L, Simpson J. A retrospective cohort study of childhood immunisation status in Northern Sydney. Aust J Public Health 1995;19:58–63.
177. Meyers D, et al. USPSTF recommendations for STI screening. Am Fam Physician 2008;77:819–24.
178. Cook RL, Hutchison SL, Ostergaard L. Systematic review: noninvasive testing for chlamydia trachomatis and neisseria gonorrhoeae. Ann Intern Med 2005;142:914–25.
179. Bourne C, et al. Sexually transmitted infections: testing guidelines for men who have sex with men. Sex Health 2008;5:189–91.
180. Preswell N, Barton D. Taking a sexual history. Aust Fam Physician 2000;29:533–9.
181. Cheney K, Wray L. Chlamydia and associated factors in an under 20s antenatal population. Aust N Z J Obstet Gynaecol 2008;48:40–3.
182. Hayman N. Chlamydia PCR screening in an indigenous health general practice clinic in Brisbane 2002–3. Brisbane: 2004.
183. Low N, et al. Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection. Health Technol Assess 2007;11:1–165.
184. Queensland Health. Indigenous sexual health service report for Brisbane Southside. Brisbane: Communicable Disease Unit, 2004.
185. Heal C, et al. Screening for chlamydia in general practice. Aust Fam Physician 2002;31:779–82.
186. Scholes D, et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996;334:1362–6.
187. The Royal Australasian College of Physicians, Australasian Chapter of Sexual Health Medicine. Clinical guidelines for the management of sexually transmissible infections among priority populations. The RACP, 2004.
188. Australasian Society for HIV Medicine. HIV, viral hepatitis and STIs: a guide for primary care. Sydney: ASHM, 2008.
189. Whittington WL, et al. Determinants of persistent and recurrent chlamydia trachomatis infection in young women: results of a multicenter cohort study. Sex Transm Dis 2001;28:117–23.
190. Orr DP, et al. Subsequent sexually transmitted infection in urban adolescents and young adults. Arch Pediatr Adolesc Med 2001;155:947–53.
191. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. MMWR 2006;55:38–40.
192. Watson E, et al. The accuracy and efficacy of screening tests for chlamydia trachomatis: a systematic review. J Med Microbiol 2002;51:1021–31.
193. Ministry of Health. Draft Chlamydia management guidelines. Wellington: Ministry of Health, 2008.
194. Hocking J, Fairley C. Need for screening for genital chlamydia trachomatis infection in Australia. Aust N Z J Public Health 2003;27:80–1.
195. Atkins D. First new screening recommendations from the third US preventive services task force. BMJ 2003;327:21–4.
196. Golden MR, Whittington WLH, Handsfield HH. Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. N Engl J Med 2005;352:676–85.
197. Honey E, et al. Cost effectiveness of screening for chlamydia trachomatis: a review of published studies. Sex Transm Infect 2002;78:406–12.
198. The Royal Australian College of General Practitioners. Smoking, nutrition, alcohol and physical activity: A population health guide to behavioural risk factors for general practices. South Melbourne: The RACGP, 2004.
199. Prochaska J, Di Clemente C. Towards a comprehensive model of change, in treating addictive behaviours : processes of change. Miller W, Heather N, editors. New York: Plenum, 1986.
200. The Royal Australian College of General Practitioners. Putting prevention into practice. Guidelines for the implementation of prevention in the general practice setting. 2nd edn. South Melbourne: The RACGP, 2006.
201. Goldstein MG, et al. Multiple behavioural risk factor interventions in primary care: summary of research evidence. Am J Prev Med 2004;27:61–79.
202. Baker A, et al. Where there’s smoke, there’s fire: high prevalence of smoking among some sub– populations and recommendations for intervention. Drug Alcohol Rev 2006;25:85–96.
203. Steptoe A, et al. Behavioural counselling to increase consumption of fruit and vegetables in lowincome adults: randomised trial. BMJ 2003;326:855–7.
204. Australian Institute of Health and Welfare. The health and welfare of Australia’s Aboriginal and Torres Strait Islander peoples. Canberra: AIHW, 2008.
205. National Health and Medical Research Council. Nutrition in Aboriginal and Torres Strait Islander peoples. Canberra: Commonwealth of Australia, 2000.
206. Australian Institute of Health and Welfare. Australia’s health. Canberra: AIHW, 2004.
207. NACCHO. National guide to a preventive health assessment in Aboriginal and Torres Strait Islander peoples. The RACGP, editor. South Melbourne: The RACGP, 2005.
208. National Health and Medical Research Council. Australian alcohol guidelines: health risks and benefits. Canberra: NHMRC, 2001.
209. Wiles NJ, et al. Socio-economic status in childhood and later alcohol use: a systematic review. Addiction 2007;102:1546–63.
210. Najman JM, Williams GM, Room R. Increasing socioeconomic inequalities in male cirrhosis of the liver mortality: Australia 1981–2002. Drug Alcohol Rev 2007;26:273–8.
211. Hasin DS, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 2007;64:830–42.
212. Johnson TP. Cultural-level influences on substance use & misuse. Subst Use Misuse 2007;42:305–16.
213. Room R. Stigma, social inequality and alcohol and drug use. Drug Alcohol Rev 2005;24:143–55.
214. Room R. Taking account of cultural and societal influences on substance use diagnoses and criteria. Addiction 2006;101:31–9.
215. Roxburgh A, Degenhardt L. Characteristics of drug-related hospital separations in Australia. Drug Alcohol Depend 2008;92:149–55.
216. Hoolahan B, et al. Co-morbid drug and alcohol and mental health issues in a rural New South Wales area health service. Aust J Rural Health 2006;14:148–53.
217. Stockdale SE, et al. Longitudinal patterns of alcohol, drug, and mental health need and care in a national sample of U.S. adults. Psychiatr Serv 2006;57:93–9.
218. Harper S, Lynch J. Trends in socioeconomic inequalities in adult health behaviors among U.S. states, 1990-2004. Public Health Rep 2007;122:177–89.
219. Luoma JB, et al. An investigation of stigma in individuals receiving treatment for substance abuse. Addict Behav 2007;32:1331–46.
220. Ministry of Health. New Zealand smoking cessation guidelines. Wellington: Ministry of Health, 2007.
221. Ivers R. A review of tobacco interventions for Indigenous Australians. Aust NZ J Pub Health 2003;27:294–9.
222. Morissette SB, et al. Anxiety, anxiety disorders, tobacco use, and nicotine: a critical review of interrelationships. Psychol Bull 2007;133:245–72.
223. Ranney L, et al. Systematic review: smoking cessation intervention strategies for adults and adults in special populations. Ann Intern Med 2006;145:845–56.
224. International Primary Care Respiratory Group. Tackling the smoking epidemic: IPCRG international guidance on smoking cessation in general practice. 2007.
225. Zwar NA, et al. Update on smoking cessation pharmacotherapy for GP. Melbourne: The RACGP, 2007.
226. Solberg L, et al. Patient satisfaction and discussion of smoking cessation during clinical visits. Mayo Clin Proc 2001;76:138.
227. Young J, Ward J. Implementing guidelines for smoking cessation: advice in Australian general practice: opinions, current practices, readiness to change and perceived barriers. Fam Pract 2001;18:14–20.
228. Sciamanna C, et al. Visit satisfaction and tailored health behavior communications in primary care. Am J Prev Med 2004;26:426–30.
229. Litt J, et al. GPs Assisting Smokers Program (GASP II): report for the six month post intervention period. Adelaide: Flinders University, 2005.
230. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. WHO Tech Rep Ser 2000;894:1-xii,1-253.
231. US Preventive Services Task Force. Screening for obesity in adults. Ann Intern Med 2003;139:930–49.
232. Lau DC, et al. 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children. CMAJ 2007;176:S1–13.
233. National Health and Medical Research Council. Clinical practice guidelines for the management of overweight and obesity in adults. Canberra: NHMRC, 2003.
234. National Health and Medical Research Council. Overweight and obesity in adults – a guide for general practitioners. Canberra: NHMRC, 2003.
235. National Heart Foundation of Australia. Management of overweight and obesity in adults. NHF, 2007.
236. Shaw K, et al. Exercise for overweight or obesity. Cochrane Database Syst Rev 2008;4.
237. National Health and Medical Research Council. Food for health: dietary guidelines for Australian adults, 2003. Available at www.nhmrc.gov.au/publications/pdf/n33.pdf.
238. Pigaone MA, et al. Counselling to promote a healthy diet in adults. A summary of the evidence for the US preventive services task force. Am J Prev Med 2003;24:75–90.
239. Ammerman A, et al. The efficacy of behavioral interventions to modify dietary fat and fruit and vegetable intake: a review of the evidence. J Prev Med 2002;35:25–41.
240. US Preventive Services Task Force. Behavioral counselling in primary care to promote a healthy diet: recommendations and rationale. Am Fam Physician 2003;67.
241. Hooper L, et al. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Heart Group. Cochrane Database Syst Rev 2007;4.
242. Brunner EJ, et al. Dietary advice for reducing cardiovascular risk. Cochrane Heart Group. Cochrane Database Syst Rev 2007;4.
243. Thompson RL, et al. Dietary advice given by a dietitian versus other health professional or self-help resources to reduce blood cholesterol. Cochrane Effective Practice and Organisation of Care Group. Cochrane Database Syst Rev 2007;4.
244. World Cancer Research Fund and American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington DC: AICR, 2007.
245. Toumbourou JW, et al. Interventions to reduce harm associated with adolescent substance use. Lancet 2007;369:1391–401.
246. Pluijm SM, et al. A risk profile for identifying community-dwelling elderly with a high risk of recurrent falling: results of a 3-year prospective study. Osteoporos Int 2006;17:417–25.
247. Fletcher PC, Hirdes JP. Risk factor for accidental injuries within senior citizens’ homes: analysis of the Canadian survey on ageing and independence. J Gerontol Nurs 2005;31:49–57.
248. Aira M, Hartikainen S, Sulkava R. Community prevalence of alcohol use and concomitant use of medication: a source of possible risk in the elderly aged 75 and older? Int J Geriatr Psychiatry 2005;20:680–5.
249. Foxcroft D, et al. Longer-term primary prevention for alcohol misuse in young people: Cochrane systematic review. Int J Epidemiol 2005;34:758–9.
250. Whitlock E, et al. Behavioral counselling interventions in primary care to reduce risky/harmful alcohol use by adults: a summary of the evidence for the US preventive services taskforce. Ann Int Med 2004;140:557–68.
251. Ballesteros J, et al. Brief interventions for hazardous drinkers delivered in primary care are equally effective in men and women. Addiction 2004;99:103–8.
252. Ballesteros J, et al. Efficacy of brief interventions for hazardous drinkers in primary care: a systematic review and meta-analysis. Alcohol Clin Exp Res 2004;28:608–18.
253. Fell JC, Voas RB. The effectiveness of reducing illegal blood alcohol concentration (BAC) limits for driving: evidence for lowering the limit to .05 BAC. J Safety Res 2006;37:233–43.
254. Lunetta P, et al. Unintentional drowning in Finland 1970–2000: a population-based study. Int J Epidemiol 2004;33:1053–63.
255. Driscoll TR, Harrison JE, Steenkamp M. Alcohol and drowning in Australia. Inj Control Saf Promot 2004;11:175–81.
256. Kaye S, Darke S. Non-fatal cocaine overdose among injecting and non-injecting cocaine users in Sydney, Australia. Addiction 2004;99:1315–22.
257. O’Kane CJ, Tutt DC, Bauer LA. Cannabis and driving: a new perspective. Emerg Med (Fremantle) 2002;4:296–303.
258. Henderson J, Gray R, Brocklehurst P. Systematic review of effects of low-moderate prenatal alcohol exposure on pregnancy outcome. BJOG 2007;114:243–52.
259. Henderson J, Kesmodel U, Gray R. Systematic review of the fetal effects of prenatal binge-drinking. J Epidemiol Community Health 2007;61:1069–73.
260. Rajendram R, Lewison G, Preedy V. Worldwide alcohol-related research and the disease burden. Alcohol Res Health 2006;41:99–106.
261. Di Castelnuovo A, et al. Alcohol dosing and total mortality in men and women: an updated metaanalysis of 34 prospective studies. Arch Intern Med 2006;166:2437–45.
262. White IR, Altmann DR, Nanchahal K. Mortality in England and Wales attributable to any drinking, drinking above sensible limits and drinking above lowest-risk level. Addiction 2004;99:749–56.
263. Sullivan LE, Fiellin DA, O’Connor PG. The prevalence and impact of alcohol problems in major depression: a systematic review. Am J Med 2005;118:330–41.
264. Morris EP, Stewart SH, Ham LS. The relationship between social anxiety disorder and alcohol use disorders: a critical review. Clin Psychol Rev 2005;25:734–60.
265. Abrams K, et al. The pharmacologic and expectancy effects of alcohol on social anxiety in individuals with social phobia. Drug Alcohol Depend 2001;64:219–31.
266. Moore AA, Whiteman EJ, Ward KT. Risks of combined alcohol/medication use in older adults. Am J Geriatr Pharmacother 2007:5:64–74.
267. Weathermon R, Crabb DW. Alcohol and medication interactions. Alcohol Res Health 1999;23:40–54.
268. Cuijpers P, Riper H, Lemmers L. The effects on mortality of brief interventions for problem drinking: a meta-analysis. Addiction 2004;99:839–45.
269. Kaner EF, et al. Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev 2007;CD004148.
270. Bertholet N, et al. Reduction of alcohol consumption by brief alcohol intervention in primary care: systematic review and meta-analysis. Arch Intern Med 2005;165:986–95.
271. Mulvihill C, Taylor L, Thom B. Prevention and reduction of alcohol misuse: evidence briefing. NHS, Health Development Agency, 2005.
272. Babor T, Higgins-Biddle J. Alcohol screening and brief intervention: dissemination strategies for medical practice and public health. Addiction 2000;95:677–86.
273. Poikolainen K. Effectiveness of brief interventions to reduce alcohol intake in primary health care populations: a meta-analysis. Prev Med 1999;28:503–9.
274. Bradley KA, et al. AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res 2007;31:1208–17.
275. Berner MM, et al. The alcohol use disorders identification test for detecting at-risk drinking: a systematic review and meta-analysis. J Stud Alcohol Drugs 2007;68:461–73.
276. Rosner S, et al. Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes. J Psychopharmacol 2008;22:11–23.
277. Kranzler HR, Gage A. Acamprosate efficacy in alcohol-dependent patients: summary of results from three pivotal trials. Am J Addict 2008;17:70–6.
278. Johnson BA. Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Biochem Pharmacol 2008;75:34–56.
279. Teesson M, et al. Substance use, dependence and treatment seeking in the United States and Australia: a cross-national comparison. Drug Alcohol Depend 2006;81:149–55.
280. Litt J, Egger G. Understanding addictions: tackling smoking and hazardous drinking, in lifestyle medicine. Egger G, Binns A, Rossner S, editors. Sydney: McGraw Hill, 2007.
281. Roche A, Freeman T. Brief interventions: good in theory but weak in practice. Drug Alcohol Rev 2004;23:11–8.
282. Aira M, et al. Factors influencing inquiry about patients’ alcohol consumption by primary health care physicians: qualitative semi-structured interview study. Fam Pract 2003;20:270–5.
283. Miller NS, et al. Why physicians are unprepared to treat patients who have alcohol- and drug-related disorders. Acad Med 2001;76:410–8.
284. Kaner EF, et al. Patient and practitioner characteristics predict brief alcohol intervention in primary care. Br J Gen Pract 2001;512:822–7.
285. Raistrick D, Heather N, Godfrey C. Review of the effectiveness of treatment for alcohol problems. London: National Treatment Agency for Substance Misuse, 2006.
286. Litt JC. Exploration of the delivery of prevention in the general practice setting, in department of general practice. Adelaide: Flinders, 2007, p. 365.
287. Kypri K, et al. Computerised screening for hazardous drinking in primary care. NZ Med J 2005;118:1–10.
288. Bonevski B, et al. Randomised controlled trial of a computer strategy to increase general practitioner preventive care. Prev Med 1999;29:478–86.
289. Selin KH. Alcohol Use Disorder Identification Test (AUDIT): what does it screen? Performance of the AUDIT against four different criteria in a Swedish population sample. Subst Use Misuse 2006;41:1881–99.
290. Babor T, Higgins-Biddle J. Alcohol screening and brief intervention: dissemination strategies for medical practice and public health. Addiction 2005;95:677–86.
291. Anderson P, et al. Engaging general practitioners in the management of hazardous and harmful alcohol consumption: results of a meta-analysis. J Stud Alcohol Drugs 2004;65:191–9.
292. Vogt F, Hall S, Marteau TM. General practitioners’ and family physicians’ negative beliefs and attitudes towards discussing smoking cessation with patients: a systematic review. Addiction 2005;100:1423–31.
293. Kaner E, et al. Promoting brief alcohol intervention by nurses in primary care: a cluster randomised controlled trial. Pat Educ Counsel 2003;51:277–84.
294. National Physical Activity Program Committee, National Heart Foundation of Australia. Physical activity and energy balance, 2007. Available at www.heartfoundation.org.au/document/NHF/QRG_PhysAct_EnergyBalance_07_Jul03_FINAL.pdf.
295. Department of Health and Aged Care. National physical activity guidelines for Australians. Canberra: Commonwealth of Australia, 1999.
296. Bauman A, et al. Getting Australia active: towards better practice for the promotion of physical activity. Melbourne: National Public Health Partnership, 2002.
297. Briffa T, Maiorana A, Allan R. National heart foundation of Australia physical activity recommendations for people with cardiovascular disease. Sydney: National Heart Foundation of Australia, 2006.
298. Bunker S, Colquhoun D, Esler M. ‘Stress’ and coronary heart disease: psychosocial risk factors. National heart foundation of Australia position statement update. Med J Aust 2003;178:272–6.
299. National Vascular Disease Prevention Alliance. Draft evidence-based practice guideline for the assessment of absolute cardiovascular disease risk. 2008.
300. National Vascular Disease Prevention Alliance. CVD absolute risk guidelines. 2008.
301. Draper G, Turrell G, Oldenburg B. Health inequalities in Australia: mortality. Canberra: Queensland University of Technology, the Australian Institute of Health and Welfare, 2004.
302. Australian Bureau of Statistics. National nutrition survey. Canberra: ABS, 1995.
303. National Health Strategy. Enough to make you sick: how income and environment affect health. Canberra: AGPS, 1992.
304. Mathers C, Schofield D. The health consequences of unemployment: the evidence. Med J Aust 1998;168:178–82.
305. Cass A, et al. Barriers to access by Indigenous Australians to kidney transplantation: the IMPAKT study. Nephrology 2004;S144–6.
306. Cass A, et al. Regional variation in the incidence of end-stage renal disease in Indigenous Australians. Med J Aust 2001;175:24–7.
307. Cass A, et al. Exploring the pathways leading from disadvantage to end-stage renal disease for Indigenous Australians. Soc Sci Med 2004;58:767–85.
308. Hoy W, et al. Low birthweight and renal disease in Australian Aborigines. Lancet 1998;352:1826–7.
309. Hoy W, et al. The multidimensional nature of renal disease: rates and associations of albuminuria in an Australian Aboriginal community. Kidney Int 1998;54:1296–304.
310. Cass A, et al. Social disadvantage and variation in the incidence of end-stage renal disease in Australian capital cities. Aust N Z J Public Health 2001;25:322–6.
311. Wiggers J, Sanson-Fisher R. Practitioner provision of preventive care in general practice consultations: association with patient education and occupational status. Soc Sci Med 1997;44:137–46.
312. Stocks N, et al. Statin prescribing in Australia: socioeconomic and sex differences. A cross sectional study. Med J Aust 2004;180:229–31.
313. National Heart Foundation of Australia. Hypertension management guide for doctors. 2008.
314. US Preventive Services Task Force. Screening for high blood pressure: U.S. preventive services task force reaffirmation recommendation statement. Ann Intern Med 2007;147:783–6.
315. Australian Institute of Health and Welfare. The health and welfare of Australia’s Aboriginal and Torres Strait Islander peoples. Canberra: AIHW, 2001.
316. Go A, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-305.
317. Culleton B, et al. Cardiovascular disease and mortality in a community–based cohort with mild renal insufficiency. Kidney Int 1999;56:2214-9.
318. National Heart Foundation of Australia, The Cardiac Society of Australia and New Zealand. Position statement on lipid management 2005. Heart Lung Circ 2005;14:275–91.
319. Bachorik PS, et al. Lipoprotein-cholesterol analysis during screening: accuracy and reliability. Ann Intern Med 1991;114:741–7.
320. Bradford RH, et al. Blood cholesterol screening in several environments using a portable, dry-chemistry analyzer and fingerstick blood samples. Lipid research clinics cholesterol screening study group. Am J Cardiol 1990;65:6–13.
321. National Health and Medical Research Council. National evidence based guidelines for the management of type 2 diabetes mellitus: primary prevention, case detection and diagnosis. Canberra: NHMRC, 2001.
322. Iseki K, et al. Proteinuria and the risk of developing end-stage renal disease. Kidney Int 2003;63:1468– 74.
323. International Diabetes Institute. The Australian type 2 diabetes risk assessment tool (Ausrisk). AGDHA, 2008.
324. Lee TJ, Safranek S. FPIN’s clinical inquiries. A1C testing in the diagnosis of diabetes mellitus. Am Fam Physician 2006;71:143–4.
325. Bennett CM, Guo M, Dharmage SC. HbA(1c) as a screening tool for detection of type 2 diabetes: a systematic review. Diabet Med 2007;24:333–43.
326. Williamson DF, Vinicor F, Bowman BA. Primary prevention of type 2 diabetes mellitus by lifestyle intervention: implications for health policy. Ann Intern Med 2004;140:951–7.
327. Knowler WC, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393–403.
328. Pan X, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: The Da Qing IGT and diabetes study. Diabetes Care 1997;20:537–44.
329. Tuomilehto J, et al. Prevention of type 2 diabetes melllitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343–50.
330. Goldstein LB, et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2006;113:e873–923.
331. New Zealand Guidelines Group. The assessment and management of cardiovascular risk, 2003. Available at www.nzgg.org.nz/guidelines/0035/CVD_Risk_Full.pdf.
332. National Heart Foundation. National heart foundation position statement on non-valvular atrial fibrillation and stroke prevention. Med J Aust 2001;174:234–348.
333. National Stroke Foundation. Clinical guidelines for acute stroke management. Canberra: AGDHA, 2007.
334. Floriani M, et al. Value and limits of ‘critical auscultation’ of neck bruits. Angionly 1988;39:967–72.
335. Sauve J, et al. Can bruits distinguish high-grade from moderate symptomatic carotid stenosis? The North American symptomatic carotid endarterectomy trial. J Ann Intern Med 1994;120:633–7.
336. Pickett CA, et al. Carotid bruit as a prognostic indicator of cardiovascular death and myocardial infarction: a meta-analysis. Lancet 2008;371:1587–94.
337. Bouleware LE, Jaar BG, Powe NR. Cost-effectiveness of screening for proteinuria – Reply. JAMA 2004;291:1443.
338. Boulware LE, et al. Screening for proteinuria in US adults. A cost-effectiveness analysis. JAMA 2003;290:3101–14.
339. Hallan SI, et al. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ 2006;333:1047.
340. Astor BC, et al. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Am J Epidemiol 2008;167:1226–34.
341. Eknoyan G, et al. Proteinuria and other markers of chronic kidney disease: a position statement of the National Kidney Foundation (NKF) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Am J Kidney Dis 2003;42:617–22.
342. Bleyer A, et al. Tobacco, hypertension, and vascular disease: risk factors for renal functional decline in an older population. Kidney Int 2000;57:2072–9.
343. Wang Y, et al. Association between obesity and kidney disease: a systematic review and metaanalysis. Kidney Int 2007;1–15.
344. de Jong PE, Curhan GC. Screening, monitoring and treatment of albuminuria: public health perspectives. J Am Soc Nephrol 2006;17:2120–6.
345. Chadban S, et al. Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J Am Soc Nephrol 2003;14:S131–8.
346. Johnson D. Evidence-based guide to slowing the progression of early renal insufficiency. Intern Med J 2004;34:50–7.
347. Fox C, et al. Predictors of new-onset kidney disease in a community-based population. JAMA 2004;291:844–50.
348. Kidney Health Australia. Chronic Kidney Disease (CKD) management in general practice. Melbourne: Kidney Health Australia, 2007.
349. Kidney Health Australia. National chronic kidney disease strategy. Melbourne: 2006.
350. Levey AS, et al. National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003;139:137–47.
351. English D, Del Mar C, Burton R. Factors influencing the number needed to excise: excision rates of pigmented lesions by general practitioners. Med J Aust 2004;180:16–9.
352. Australian Institute of Health and Welfare. Cervical screening in Australia 2000–2001 and 1999–2000. Canberra: AIHW, 2003.
353. Faggiano F, et al. Socioeconomic differences in cancer incidence and mortality. IARC Sci Publ 1999;138:65–176.
354. Taylor V, et al. Colorectal cancer screening among African Americans: the importance of physician recommendation. J Natl Med Assoc 2003;95:806–12.
355. McCaffery K, et al. Socioeconomic variation in participation in colorectal cancer screening. J Med Screen 2002;9:104–8.
356. Tong S, et al. Socio-demographic correlates of screening intention for colorectal cancer. Aust N Z J Public Health 2000;24:610–4.
357. Katz S, Hofer T. Socioeconomic disparities in preventive care persist despite universal coverage. Breast and cervical cancer screening in Ontario and the United States. JAMA 1994;272:530–4.
358. Shelley J, et al. Who has pap smears in New South Wales? Patterns of screening across sociodemographic groups. Aust J Public Health 1994;18:406–11.
359. O’Byrne A, et al. Predictors of non-attendance for second round mammography in an Australian mammographic screening programme. J Med Screen 2000;7:190–4.
360. Gefeller O, Pfahlberg A. Sunscreen use and melanoma: a case of evidence-based prevention? Photodermatol Photoimmunol Photomed 2002;18:153–6.
361. Marks R. Photoprotection and prevention of melanoma. Eur J Dermatol 1999;9:406–12.
362. Azizi E, et al. Use of sunscreen is linked with elevated naevi counts in Israeli school children and adolescents. Melanoma Res 2000;10:491–8.
363. Huncharek M, Kupelnick B. Use of topical sunscreens and the risk of malignant melanoma: a meta– analysis of 9067 patients from 11 case-control studies. Am J Public Health 2002;92:1173–7.
364. English DR, Milne E, Simpson JA. Sun protection and the development of melanocytic nevi in children. Cancer Epidemiol Biomarkers Prev 2005;14:2873–6.
365. National Health and Medical Research Council. The management of cutaneous melanoma: clinical practice guideline. Canberra: NHRMC, 1999.
366. MacKie R, McHenry P, Hole D. Accelerated detection with prospective surveillance for cutaneous malignant melanoma in high-risk groups. Lancet 1993;341:1618–20.
367. New Zealand Dermatological Society. New Zealand guidelines on the general management of malignant melanoma. New Zealand: 2004.
368. Baade PD, et al. Community perceptions of suspicious pigmented skin lesions: are they accurate when compared to general practitioners? Cancer Detect Prev 2005;29:267–75.
369. Hanrahan P, et al. A randomised trial of skin photography as an aid to screening skin lesions in older males. J Med Screen 2002;9:128–32.
370. Smith W. Skin cancer in Australia and the case for screening in general practice. Brisbane: University of Queensland, 2003.
371. Kelly J, et al. Nodular melanoma. No longer as simple as ABC. Aust Fam Physician 2003;32:706–9.
372. Scope A, et al. The ‘ugly duckling’ sign: agreement between observers. Arch Dermatol 2008;144:58– 64.
373. Zalaudek I, et al. Time required for a complete skin examination with and without dermoscopy: a prospective, randomized multicenter study. Arch Dermatol 2008;144:509–13.
374. Kanzler M, Mraz-Gernhard S. Primary cutaneous malignant melanoma and its precursor lesions: diagnostic and therapeutic overview. J Am Acad Dermatol 2001;45:260–76.
375. Green A, et al. Daily sunscreen application and betacarotene supplementation in prevention of basalcell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet 1999;354:723–9.
376. National Health and Medical Research Council. Clinical practice guidelines non-melanoma skin cancer: guidelines for treatment and management in Australia. Canberra: NHMRC, 2002.
377. Czarnecki D, et al. The development of non-melanocytic skin cancers in people with a history of skin cancer. Dermatology 1994;189:364–7.
378. National Health and Medical Research Council. Screening to prevent cervical cancer: guidelines for the management of asymptomatic women with screen detected abnormalities. Canberra: NHMRC, 2005.
379. Skinner SR, et al. Human papillomavirus vaccination for the prevention of cervical neoplasia: is it appropriate to vaccinate women older than 26? Med J Aust 2008;188:238–42.
380. EUROGIN, conclusions: cervical cancer control, priorities and new directions: international charter. France: 2003.
381. Buntinx F, Brouwers M. Relation between sampling device and detection of abnormality in cervical smears: a meta-analysis of randomised and quasi-randomised studies. BMJ 1996;313:1285–90.
382. Mayrand MH, et al. Canadian cervical cancer screening trial study group. Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer. N Engl J Med 2007;357:1579–88.
383. Koliopoulos G, et al. Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies. Gynecol Oncol 2007;104:232–46.
384. Safaeian M, et al. Risk of precancer and follow-up management strategies for women with human papillomavirus–negative atypical squamous cells of undetermined significance. Obstet Gynecol 2007;109:1325-31.
385. Arbyn M, et al. Virologic versus cytologic triage of women with equivocal pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst 2004;96:280–93.
386. Arbyn M, et al. Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence. Gynecol Oncol 2005;99:S7–11.
387. Davey E, et al. Effect of study design and quality on unsatisfactory rates, cytology classifications, and accuracy in liquid–based versus conventional cervical cytology: a systematic review. Lancet 2006;367:122–32.
388. Ronco G, et al. Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial. BMJ 2007;335:28.
389. Forbes C, Jepson R, Martin-Hirsch P. Interventions targeted at women to encourage the uptake of cervical screening. Cochrane Database Syst Rev 2008;1.
390. The Cancer Council Australia. National cancer prevention policy 2007–2009. NSW: The Cancer Council Australia, 2007.
391. National Breast Cancer Centre. Advice about familial aspects of breast cancer and ovarian cancer: a guide for health professionals, 2006. Available at www.nbocc.org.au/bestpractice/resources/BOG182_adviceaboutfamiliala.pdf.
392. National Breast Cancer Centre. Position statement: Early detection of breast cancer, 2004. Available at www.nbocc.org.au/resources/documents/EDP_earlydetectionposition0804.pdf.
393. National Breast Cancer Centre. Screening women aged 40–49: A summary of the evidence for health professionals, 1998. Available at www.nbocc.org.au/bestpractice/resources/HPI_40–49screening.pdf.
394. National Breast Cancer Centre. Effectiveness and cost effectiveness of screening mammography in women over the age of 70 years, 2002. Available at www.nbocc.org.au/bestpractice/resources/SMW_70plus_report_fmt.pdf.
395. Semiglazov V, et al. Interim results of a prospective randomised study of self–examination for early detection of breast cancer. Vopr Onkil 1999;45:265–71.
396. Thomas D, et al. Randomised trial of breast self-examination in Shanghai: final results. J Nat Can Inst 2002;94:1445–57.
397. Thune I, et al. Physical activity and the risk of breast cancer. N Engl J Med 1997;336:1269–75.
398. International Agency for Research on Cancer. Weight control and physical activity. Lyon: IARC, 2002.
399. Kujan O, et al. Screening programmes for the early detection and prevention of oral cancer. Cochrane Database Syst Rev 2003;4.
400. Kosters JP, Gotzsche PC. Regular self-examination or clinical examination for early detection of breast cancer. Cochrane Database Syst Rev 2008;1.
401. Bonfill X, et al. Strategies for increasing the participation of women in community breast cancer screening. Cochrane Database Syst Rev 2008;1.
402. US Preventive Services Task Force. Screening for oral cancer: recommendation statement. Rockville: Agency for Healthcare Research and Quality, 2004.
403. Sugerman P, Savage N. Current concepts in oral cancer. Aust Dent J 1999;44:147–56.
404. Australian Cancer Network Colorectal Cancer Guidelines Revision Committee. Guidelines for the prevention, early detection and management of colorectal cancer. Sydney: The Cancer Council Australia and Australian Cancer Network, 2005.
405. Zauber AG, et al. Evaluating test strategies for colorectal cancer screening: a decision analysis for the US preventive services task force. Ann Intern Med 2008;60520–4.
406. Cole SR, et al. Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement from the primary care practitioner. J Med Screen 2002;9:147–52.
407. Salked GP, et al. Measuring the attributes that influence consumer attitudes to colorectal cancer screening. ANZ J Surgery 2003;73:128–32.
408. Towler BP, et al. Screening for colorectal cancer using the faecal occult blood test, hemoccult. Cochrane Database Syst Rev 2000;2:CD001216.
409. National Cancer Institute. Colorectal cancer screening, 2008. Available at www.cancer.gov/cancertopics/pdq/screening/colorectal/HealthProfessional/page4.
410. Australian Cancer Network. Familial aspects of bowel cancer: A guide for health professionals, 2008. Available at: www.cancerscreening.gov.au/internet/screening/publishing.nsf/Content/bw-familialguide/$File/familial-guide.pdf.
411. US National Cancer Institutes. Genetics of colorectal cancer, 2008. Available at www.cancer.gov/cancertopics/pdq/genetics/colorectal/HealthProfessional/page1.
412. Australian Government Department of Health and Ageing. National bowel cancer screening program, 2007. Available at www.cancerscreening.gov.au/internet/screening/publishing.nsf/Content/bowel-1lp.
413. US Preventive Services Task Force. Screening for testicular cancer: recommendation statement. Rockville: Agency for Healthcare Research and Quality, 2004.
414. Elford RW. Screening for testicular cancer, in Canadian task force on the periodic health examination. Canadian guide to clinical preventive health care. Ottawa: Health Canada, 1994, p. 892–8.
415. National Cancer Institute. Testicular cancer screening, 2008. Available at www.cancer.gov/cancertopics/pdq/screening/testicular/Patient/page3.
416. US Preventive Services Task Force. Screening for prostate cancer. Ann Intern Med 2002;137:915–6.
417. Lim LS, Sherin K, ACPM Prevention Practice Committee. Screening for prostate cancer in U.S. men: ACPM position statement on preventive practice. Am J Prev Med 2008;34:164–70.
418. Ilic D, et al. Screening for prostate cancer. Cochrane Database Syst Rev 2006;3:CD004720.
419. Ilic D, Green S. Screening for prostate cancer in younger men. BMJ 2007;335:1105–6.
420. National Health and Medical Research Council. Clinical practice guidelines for the management of uncomplicated lower urinary tract symptoms in men. Canberra: NHMRC, 1997.
421. Zeegers MP, Jellema A, Ostrer H. Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis. Cancer 2003;97:1894–903.
422. Liede A, Karlan BY, Narod SA. Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. J Clin Oncol 2004;22:735–42.
423. Gattellari M, Ward J. Does evidence-based information about screening for prostate cancer enhance consumer decision-making? A randomised controlled trial. J Med Screen 2003;10:27–29.
424. Henderson S, Andrews G, Hall W. Australia’s mental health: an overview of the general population survey. Aust N Z J Psychiatry 2000;34:197–205.
425. Lorant V, et al. Socioeconomic inequalities in depression: a meta-analysis. Am J Epidemiol 2003;157:98–112.
426. Comino E, et al. Relationship between mental health disorders and unemployment status in Australian adults. Aust N Z J Psychiatry 2003;37:230–5.
427. Averill P, et al. Correlates of depression in chronic pain patients: a comprehensive examination. Pain 1996;65:93–100.
428. Ostler K, et al. Influence of socio-economic deprivation on the prevalence and outcome of depression in primary care: the Hampshire depression project. Br J Psychiatry 2001;178:12–7.
429. Lynch J, et al. Is income inequality a determinant of population health? Part 2. U.S. national and regional trends in income inequality and age-and cause-specific mortality. Milbank Q 2004;82:355– 400.
430. Neeleman J. Beyond risk theory: suicidal behavior in its social and epidemiological context. Journal of Crisis Intervention & Suicide 2002;23:114–20.
431. Welch S. A review of the literature on the epidemiology of parasuicide in the general population. Psychiatr Serv 2001;52:368–75.
432. Stack S. Suicide: a 15-year review of the sociological literature. Part I: cultural and economic factors. Suicide Life Threat Behav 2000;32:145–62.
433. Hunter E, Harvey D. Indigenous suicide in Australia, New Zealand, Canada, and the United States. Emerg Med 2002;14:14–23.
434. Beautrais A. Risk factors for suicide and attempted suicide among young people. A literature review prepared for the NHMRC. Canberra: AGPS, 1998.
435. Cantor C. The epidemiology of suicide and attempted suicide among young Australians. A literature review prepared for the NHMRC. Canberra: AGPS, 1998.
436. Beautrais A, Joyce P, Mulder R. Unemployment and serious suicide attempts. Psychol Med 1998;28:209–18.
437. Pignone M, et al. Screening for depression. Systematic Evidence Review No. 6. Rockville: AHRQ, 2002.
438. MacMillan H, Patterson CJS, Wathen CN. Screening for depression in primary care: recommendation statement from the Canadian task force on preventive health care. CMAJ 2005;172:33–5.
439. National Collaborating Centre for Mental Health. Depression: management of depression in primary and secondary care. London: NICE, 2004.
440. Feightner JW. Early detection of depression, in Canadian task force on the periodic health examination. Canadian guide to clinical preventive health care. Ottawa: Health Canada, 1994, p. 450–4.
441. Arroll B, et al. Effect of the addition of a ‘help’ question to two screening questions on specificity for diagnosis of depression in general practice: diagnostic validity study. BMJ 2005;331:884.
442. Gaynes B N, West SL, et al. Screening for suicide risk in adults: a Summary of the evidence for the U.S. preventive services task force. Ann Intern Med 2004;140:822–35.
443. Goldney RD. Suicide prevention: a pragmatic review of recent studies. Crisis 2005;26:128–40.
444. Hall W, et al. Association between antidepressant prescribing and suicide in Australia, 1991–2000 trend analysis. BMJ 2003;326:1008–12.
445. McNamee J, Offord D. Prevention of suicide, in the Canadian guide to clinical preventive health care. Ottawa: Health Canada, 1994, p. 455–67.
446. US Preventive Services Task Force. Screening for suicide risk, topic page. Rockville: Agency for Healthcare Research and Quality, 2004.
447. New Zealand Guidelines Group. The assessment and management of people at risk of suicide, 2003. Available at www.nzgg.org.nz/guidelines/0005/Suicide_Guideline.pdf.
448. Victorian Government Department of Justice. Management of the whole family when intimate partner violence is present: guidelines for primary care physicians, 2006. Available at www.racgp.org.au/guidelines/intimatepartnerabuse.
449. Sohal H, Eldridge S, Feder G. The sensitivity and specificity of four questions (HARK) to identify intimate partner violence: a diagnostic accuracy study in general practice. BMC Fam Pract 2007;8:49– 52.
450. US Preventive Services Task Force. Prevention of dental caries in preschool children. Am J Prev Med 2004;26:326–9.
451. National Health and Medical Research Council. A systematic review of the efficacy and safety of fluoridation. Canberra: Australian Government, 2007.
452. National Health and Medical Research Council. Review of water fluoridation and fluoride intake from discretionary fluoride supplements review. Canberra: NHMRC, 1999.
453. Nordblan A. Smart habit xylitol campaign: a new approach in oral health promotion. Comm Dental Health 1995;12:230–4.
454. AIHW Dental Statistics and Research Unit. Research report No 9. Social determinants of oral health. Canberra: AIHW, 2003.
455. US Preventive Services Task Force. Screening for glaucoma. Ann Fam Med 2005;3:171–2.
456. Cockburn D. Diagnosis and management of open angle glaucoma: suggested guidelines for optometrists. Clin Exp Optom 2000;83:119–27.
457. Weston B, Aliabadi A, White G. Glaucoma – review for the vigilant clinician. Clin Rev 2000;10:59–74.
458. American Academy of Ophthalmology. Comprehensive adult medical eye evaluation, preferred practice pattern, 2005. Available at www.aao.org/ppp.
459. McComiskie J, Greer R, Gole G. Panoptic versus conventional ophthalmoscope. Clin Exp Ophthal 2004;32:238.
460. Continence Foundation of Australia. Promoting bladder and bowel health, 2008. Available at www.continence.org.au/health_facts.html.
461. Shamliyan T, et al. Prevention of fecal and urinary incontinence in adults. Evidence report/technology assessment No. 161. Rockville: Agency for Healthcare Research and Quality, 2007.
462. O’Neil B, Gilmour D. Approach to urinary incontinence in women. Diagnosis and management by family physicians. Can Fam Physician 2003;49:611–8.
463. US Preventive Services Task Force. Screening for osteoporosis in post-menopausal women, 2002. Available at www.ahrq.gov/clinic/3rduspstf/osteoporosis/osteorr.htm.
464. Royal College of Physicians. Osteoporosis: clinical guidelines for prevention and treatment. London: RCP, 1999.
465. Canadian Task Force on Preventive Health Care. Prevention of osteoporosis and osteoporotic fractures in postmenopausal women: recommendation statement from the Canadian task force on preventive health care. CMAJ 2004;170.
466. Norman P, et al. Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm. BMJ 2004;329:1259.
467. Stewart RA, Thistlethwaite J. Routine pelvic examination for asymptomatic women – exploring the evidence. Aust Fam Physician 2006;35:873–7.
468. Wilkin T, Devendra D. Bone densitometry is not a good predictor of hip fracture. BMJ 2001;323:795–9.
469. The Australian Cancer Network, National Breast Cancer Centre. Clinical practice guidelines for the management of women with epithelial ovarian cancer. Camperdown: National Breast Cancer Centre, 2004.
470. Marcus P, et al. Lung cancer mortality in the mayo lung project: impact of extended follow-up. J Natl Cancer Inst 2000;92:1308–16.
471. US Preventive Services Task Force. Screening for coronary heart disease. Summary of recommendations. 2004.
472. Hill J, Timmis A. Exercise tolerance testing. BMJ 2002;324:1084–7.
473. Elwood M, Campbell D, De Campo M. Helical computed tomography for lung cancer screening. Med J Aust 2003;179:125–6.
474. Kirkpatrick P, McConnell R. Screening for familial intracranial aneurysms. BMJ 1999;319:1512–3.
475. Pinnock C. PSA testing in general practice: can we do more now? Med J Aust 2004;180:379–81.
476. van Schayck C, et al. Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study. BMJ 2002;324:1370.
477. Nicolle L. Screening of asymptomatic bactereuria in the elderly. In: Canadian Task Force on Preventive Health Care. Ottawa: Health Canada, 1993.
478. Weetman A. Hypothyroidism: screening and subclinical disease. BMJ 1997;314:1175.
479. Brenner DJ, Hall EJ. Computerised tomography: an increasing source of radiation exposure. N Engl J Med 2007;357:2277–84.
© The Royal Australian College of General Practitioners
Printed from www.racgp.org.au/redbook